Overview

A Study to Evaluate Oral Salmon Calcitonin in the Treatment of Osteoporosis in Postmenopausal Women Taking Calcium and Vitamin D

Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this Phase III study is to evaluate the efficacy and safety of oral salmon calcitonin in the treatment of patients with osteoporosis
Phase:
Phase 3
Details
Lead Sponsor:
Nordic Bioscience A/S
Collaborator:
Novartis
Treatments:
Calcitonin
Calcitonin Gene-Related Peptide
Katacalcin
Salmon calcitonin
Vitamin D